Doseology Engages McKinney Regulatory Science Advisors to Advance Innovative Oral Pouch Product Development through Science and Regulatory Expertise

Core Insights - Doseology Sciences Inc. has announced a strategic partnership with McKinney Regulatory Science Advisors to enhance its regulatory submission strategy and establish leadership in the oral pouch technology sector [1][2] Group 1: Partnership Overview - The collaboration aims to transition Doseology towards regulatory execution and commercial readiness, with McKinney providing guidance on formulation strategy, data generation, PMTA preparation, and post-market compliance [2][3] - This partnership emphasizes Doseology's commitment to scientific leadership and consumer safety in the oral pouch category [3] Group 2: McKinney's Role and Contributions - McKinney will expedite Doseology's navigation of FDA requirements, aiming to streamline development timelines and reduce regulatory uncertainty [6] - The partnership will enhance Doseology's intellectual property by aligning formulation and testing strategies with regulatory standards, ensuring dose consistency and delivery performance [6] - McKinney will assist in comprehensive PMTA readiness, covering both nicotine and innovative nicotine-analogue formulations [6] Group 3: Commitment to Safety and Compliance - The collaboration underscores Doseology's commitment to developing safe and effective products, with McKinney's expertise guiding the prioritization of necessary studies and documentation [6] - McKinney will conduct a regulatory landscape assessment for various pouch formats and define specific data and testing requirements to support anticipated claims and submissions [6]